Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer.

Patricia Clara Ryan,John L. Jakubczak,David A. Stewart,Lynda K. Hawkins,Cheng Cheng,Lori M Clarke,Shanthi Ganesh,Carl Hay,Ying Huang,Michele Kaloss,Anthony Marinov,Sandrina Phipps,P. Seshidhar Reddy,Pamela S. Shirley,Yelena Skripchenko,Ling Xu,Jingping Yang,Suzanne Forry-Schaudies,Paul L. Hallenbeck

Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer.

2004

Patricia Clara Ryan
John L. Jakubczak
David A. Stewart
Lynda K. Hawkins
Cheng Cheng
Lori M Clarke
Shanthi Ganesh
Carl Hay
Ying Huang
Michele Kaloss
Anthony Marinov
Sandrina Phipps
P. Seshidhar Reddy
Pamela S. Shirley
Yelena Skripchenko
Ling Xu
Jingping Yang
Suzanne Forry-Schaudies
Paul L. Hallenbeck

Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer

Keywords:

Biology
Cancer
Virology
Oncolytic adenovirus
Carcinogenesis
Oncolytic virus
Telomerase reverse transcriptase
LNCaP
Cancer cell
cell killing

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations